OREX

Orexigen Therapeutics, Inc. News Headlines

$4.35
*  
0.29
7.14%
Get OREX Alerts
*Delayed - data as of Oct. 21, 2014 9:50 ET  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OREX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Orexigen: Poised To Grab A Large Part Of The Weight Loss Market
9/12/2014 1:40:00 PM - Seeking Alpha


Belviq Advertising Sees Major Shift
9/12/2014 1:22:00 PM - Seeking Alpha


Surprising New Competitor: Should Arena Pharmaceuticals, Inc. and Orexigen Therapeutics, Inc. Be Afr
9/12/2014 9:09:40 AM - Motley Fool


A New Nifty Fifty States Stock Index
9/12/2014 12:46:00 AM - Seeking Alpha


FDA Approves Orexigen Therapeutics Inc.'s Goldilocks Obesity Drug
9/11/2014 4:46:01 PM - Motley Fool


Sector Update: Health Care Stocks Sit Out Late Rise For Stocks; Orexigen Slammed After FDA 'Black Label'
9/11/2014 4:04:37 PM - MT Newswires


Sector Update: Health Care
9/11/2014 4:02:39 PM - MT Newswires


Skinny pill approved!
9/11/2014 11:32:00 AM - Market Intelligence Center


Orexigen's Contrave Approved: What It Means To Arena
9/11/2014 10:02:00 AM - Seeking Alpha


FDA Approves Orexigen's Contrave For Obesity Treatment
9/11/2014 9:22:00 AM - Seeking Alpha


Sector Update: Health Care
9/11/2014 8:38:24 AM - MT Newswires


Sector Update: Healthcare shares Mixed in Pre-Market Trade
9/11/2014 8:37:28 AM - MT Newswires


FDA Approves Orexigen's Diet Drug Contrave
9/11/2014 8:35:00 AM - Dow Jones Business News


FDA Okays Orexigen Therapeutics' Weight-Loss Drug Contrave
9/11/2014 6:07:00 AM - RTT News


Why Arena Pharmaceuticals, Inc. Stock Crashed By 31% in 2014
9/9/2014 9:45:02 AM - Motley Fool


Orexigen Gets Weight Loss Drug Patent, May See Runup Into Approval Decision
9/5/2014 11:46:00 AM - Seeking Alpha


Belviq Sales Crack Critical Level
8/29/2014 4:46:00 PM - Seeking Alpha


Vivus Acquires Patent Rights To Qsymia Ingredient
8/25/2014 1:38:00 PM - Seeking Alpha


Belviq Sales Rise 2%
8/25/2014 9:57:00 AM - Seeking Alpha


Belviq Sales Flatten Out But Edge Above Qsymia
8/15/2014 4:10:00 PM - Seeking Alpha


Arena's Belviq Bucks Seasonality With 3.6% Week Over Week Gain
8/8/2014 1:28:00 PM - Seeking Alpha


Vivus Beats The Street - Still Has A Loss
8/8/2014 10:04:00 AM - Seeking Alpha


Orexigen Therapeutics Reports Wider Q2 Loss as Costs Mount - Analyst Blog
8/8/2014 9:20:00 AM - Zacks.com


Orexigen Hits Expectations But That Is Not The Big News
8/7/2014 1:25:00 PM - Seeking Alpha


2nd Half Of 2014 Biotechnology Catalysts-Part 3
8/4/2014 2:36:00 PM - Seeking Alpha